Facioscapulohumeral Muscular Dystrophy (FSHD) Latest Advances

Find the Latest Research About Facioscapulohumeral Muscular Dystrophy (FSHD)

Last Updated: 04/28/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1427 publications

Identification of compounds that repress DUX4 expression in facioscapulohumeral muscular dystrophy.

Identification of compounds that repress DUX4 expression in facioscapulohumeral muscular dystrophy.

Journal: bioRxiv : the preprint server for biology
Published: March 27, 2026

Long-read sequencing and the evolving landscape of facioscapulohumeral muscular dystrophy diagnosis.

Long-read sequencing and the evolving landscape of facioscapulohumeral muscular dystrophy diagnosis.

Journal: Brain : a journal of neurology
Published: March 26, 2026

What Is in the Myopathy Literature?

What Is in the Myopathy Literature?

Journal: Journal of clinical neuromuscular disease
Published: March 02, 2026

SMCHD1 loss re-wires MYOD1 enhancer nexuses and chromatin accessibility landscapes in muscle cells.

SMCHD1 loss re-wires MYOD1 enhancer nexuses and chromatin accessibility landscapes in muscle cells.

Journal: bioRxiv : the preprint server for biology
Published: February 27, 2026

Respiratory insufficiency and sleep impairment in facioscapulohumeral muscular dystrophy.

Respiratory insufficiency and sleep impairment in facioscapulohumeral muscular dystrophy.

Journal: Neuromuscular disorders : NMD
Published: February 09, 2026

A randomized, double-blind, placebo-controlled study of losmapimod in patients with facioscapulohumeral muscular dystrophy: Results of the REACH study.

A randomized, double-blind, placebo-controlled study of losmapimod in patients with facioscapulohumeral muscular dystrophy: Results of the REACH study.

Journal: Journal of neuromuscular diseases
Published: February 06, 2026

Facial Weakness in Facioscapulohumeral Muscular Dystrophy: Objective and Patient-Reported Measures to Guide Reconstructive Interventions.

Facial Weakness in Facioscapulohumeral Muscular Dystrophy: Objective and Patient-Reported Measures to Guide Reconstructive Interventions.

Journal: Facial plastic surgery & aesthetic medicine
Published: February 04, 2026

Ultrasound Contrast between the Trapezius and Supraspinatus Muscles as a Potentially Specific Finding of Facioscapulohumeral Muscular Dystrophy.

Ultrasound Contrast between the Trapezius and Supraspinatus Muscles as a Potentially Specific Finding of Facioscapulohumeral Muscular Dystrophy.

Journal: Internal medicine (Tokyo, Japan)
Published: February 01, 2026

Overview of facioscapulohumeral dystrophy clinical features and diagnostic pathway.

Overview of facioscapulohumeral dystrophy clinical features and diagnostic pathway.

Journal: Neuromuscular disorders : NMD
Published: January 15, 2026

Genome-wide analysis of FSHD cell lines using Nanopore sequencing reveals allele-specific differences at DUX4 target genes and complex repeats.

Genome-wide analysis of FSHD cell lines using Nanopore sequencing reveals allele-specific differences at DUX4 target genes and complex repeats.

Journal: bioRxiv : the preprint server for biology
Published: January 09, 2026

Predictive value of D4Z4 methylation levels for phenotypic heterogeneity and disease progression in Facioscapulohumeral Muscular Dystrophy with borderline D4Z4 repeat units: a retrospective cohort study.

Predictive value of D4Z4 methylation levels for phenotypic heterogeneity and disease progression in Facioscapulohumeral Muscular Dystrophy with borderline D4Z4 repeat units: a retrospective cohort study.

Journal: PeerJ
Published: January 02, 2026

A toolkit for new facioscapulohumeral muscular dystrophy trial sites.

A toolkit for new facioscapulohumeral muscular dystrophy trial sites.

Journal: Journal of neuromuscular diseases
Published: December 26, 2025
Showing 1-12 of 1,427

Last Updated: 04/28/2026